Madrigal Pharmaceuticals

Develops and commercializes therapeutics for metabolic dysfunction-associated steatohepatitis.

Founded 2000 · 915 employees · United States · Public

PharmaceuticalsBiotechnology
Listed:
NASDAQ: MDGL
madrigalpharma.com ↗